You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 26, 2024

Generic Companies with Tentative Approvals for: Lupin Ltd


✉ Email this page to a colleague

« Back to Dashboard


Lupin Ltd Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Lupin Ltd pregabalin 201989 20MG/ML SOLUTION; ORAL
Lupin Ltd norethindrone acetate;ethinyl estradiol;ferrous fumarate 203113 1MG;0.01MG;75MG TABLET;ORAL
Lupin Ltd empagliflozin;metformin hydrochloride 213654 12.5MG; 1GM TABLET, EXTENDED RELEASE;ORAL
Lupin Ltd fesoterodine fumarate 204893 4MG TABLET, EXTENDED RELEASE;ORAL
Lupin Ltd balsalazide disodium 206529 1.1GM TABLET;ORAL
Lupin Ltd diclofenac 207393 18MG CAPSULE;ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.